Mannkind (MNKD) Operating Margin Growth (1y) (2017 - 2026)
Mannkind (MNKD) Operating Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Mannkind |
1.13 Bn |
995.19 Mn |
82.66 Mn |
-3,030.00 |
| Date | Value |
| Mar 31, 2026 |
-3,030.00 |
| Dec 31, 2025 |
-4,138.00 |
| Sep 30, 2025 |
480.00 |
| Jun 30, 2025 |
-1,602.00 |
| Mar 31, 2025 |
322.00 |
| Dec 31, 2024 |
2,107.00 |
| Sep 30, 2024 |
826.00 |
| Jun 30, 2024 |
1,941.00 |
| Mar 31, 2024 |
4,000.00 |
| Dec 31, 2023 |
4,891.00 |
| Sep 30, 2023 |
3,922.00 |
| Jun 30, 2023 |
682,154.00 |
| Mar 31, 2023 |
16,249.00 |
| Dec 31, 2022 |
15,604.00 |
| Sep 30, 2022 |
39.00 |
| Jun 30, 2022 |
-677,387.00 |
| Mar 31, 2022 |
-14,174.00 |
| Dec 31, 2021 |
-6,276.00 |
| Sep 30, 2021 |
2,980.00 |
| Jun 30, 2021 |
391,337.00 |